Polarean Imaging Share Discussion Threads

[adorling] 30/4/2021 13:04

The potential here (only for LTH’s of course) is that POLX could become the de facto imaging choice for pulmonary, respiratory and oncology imaging which will be worth £billions worldwide. IMO we are looking at a truly great technology Company with the potential to become a FTSE 100 Company within 4-5 years if not sooner if we are not taken out which is likely of course.

This is wholly dependent on the FDA Licence being granted on or before the 5th October (less than 6 months away). Given the success of the phase 3 trials compared to X-Ray and the consultative meetings with the FDA with POLX Rapporteurs to ensure all submissions requirements are fully met I cannot see the outcome being anything other than positive and have added several times this past month to build a significant shareholding.

[rhatton] 30/4/2021 11:49

Maybe we will not be waiting until October. Could be over the summer sometime

[acuere] 30/4/2021 11:21

Elliott Wave theory is to do with the psychology of investors. So FOMO fits into that.

[ridicule] 30/4/2021 11:10

Never mind Elliot Wave theory, FOMO beginning to kick in.

[acuere] 30/4/2021 11:00

To clarify, I’m looking at the chart and thinking Elliot Wave theory.
1st Wave 40p to 80p.
2nd Wave down to 60p.
If theory plays out, this 3rd Wave up would on average be 50% bigger than Wave 1, ie 60p. So I’m thinking a move from 60p to 120p is on the cards.

[acuere] 30/4/2021 10:40

Fingers crossed we’ve finally smashed through the 80p barrier. This could get to 120p very quickly now.

[markstevenkirby80] 30/4/2021 10:13

It's a ticking time bomb

[markstevenkirby80] 27/4/2021 11:56

Going to be mega

[74tom] 27/4/2021 11:18

The delayed 101028 buy has certainly shaken the MM's up, just shows how tightly held the shares are here, it really won't take much to kick us onto the £1 level, in a similar manner to the move we saw late last year from 50-80p.

@rHatton, none that I'm aware of, most IPO after they have approval in the bag - I guess scaling up is much easier to sell to investors than funding clinical trials... certainly a lot lower risk. I suspect we'll hit at £250m-300m cap upon approval (4DX on the ASX is £268m and received approval last year, so we will be in a very similar position once through the FDA hoop, albeit I think POLX is superior).

[markstevenkirby80] 27/4/2021 09:43

Small top up ,

[rhatton] 26/4/2021 17:37

Anyone with experience of similar ‘device’ companies and what they’ve done on approval?

[supernumerary] 26/4/2021 17:04

Ah, I see. Unfortunately I'm getting ever more reluctant to click blind links :( I shall just have to imagine the clock and the rockets. Not for the first time :)

[loglorry1] 26/4/2021 16:48

It's a rampy countdown clock until FDA. I couldn't work out how to add rockets unfortunately ;-)

[supernumerary] 26/4/2021 16:24

Why, what's it about?

[loglorry1] 26/4/2021 15:28

hxxps://countingdownto.com/countdown-pages/0yHOiQfF

Please share widely

[supernumerary] 26/4/2021 12:11

Thanks for the clarification, I was wondering whether minter or munter :)

[markstevenkirby80] 26/4/2021 08:04

Monter in the making

[rhatton] 24/4/2021 20:35

Interesting I’ll have a listen to the podcast.

Just to add balance, I don’t think the billion £ valuation came from 100 machines. Can be found here. I could be mistaken though



Released a new video today so apologies in terms of my understanding of the old one

[mavern] 24/4/2021 19:30

Some excellent coverage on Justin Waites weekend podcast from 20m 45s to 23 minutes - He says “Share price will start rising way ahead of expected FDA approval in early October” and “Polarean estimate they can do 25 institutions per year for the next 4 years. JW did conservative estimate of just 15 institutions per year which would give a market cap of £1B by 2027”. That’s 7 x current market cap assuming no further dilution. hxxps://audioboom.com/posts/7851726-the-weekend-podcast